Navigation Links
Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
Date:12/16/2008

SAN DIEGO, Calif., Dec. 16 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext US: CXM) and its operating unit InnerCool Therapies, Inc., today announced enrollment of the first patient in a study of Hypothermic Radical Prostatectomybeing conducted by researchers at the University of California, Irvine. The patient was cooled with InnerCool's new UroCool(TM), a pelvic catheter system designed to induce localized cooling during robotic-assisted prostatectomy surgery.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

The study is designed to evaluate the potential safety and confirm the benefits of localized cooling during robotic-assisted prostatectomy, which is now the most common surgical technique for prostate cancer. The study is being conducted by Thomas E. Ahlering, M.D., Professor and Vice Chair of the Department of Urology and his colleague Dr. David S. Finley M.D. at the University of California, Irvine. Dr. Ahlering is an expert in the field of prostate surgery, particularly in the rapidly expanding use of robotic-assisted prostatectomy systems such as the da Vinci system, which is a product of Intuitive Surgical, Inc. A regulatory application for FDA 510(k) clearance of InnerCool's UroCool catheter is expected to be submitted in the first quarter of 2009.

The UroCool(TM) catheter is designed to be placed within the rectal cavity adjacent to the prostate during surgery and is used in conjunction with InnerCool's Celsius Control Console which circulates cold saline in a closed loop within InnerCool's UroCool catheter to allow for localized cooling. Drs. Ahlering and Finley believe that therapeutic cooling of the prostate gland and surrounding areas during prostate surgery (which includes both traditional open surgical approaches and the newer robotic-a
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
2. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
3. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
4. Cardium Announces InnerCools New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
5. Cardium Announces FDA 510(K) Clearance of InnerCools RapidBlue(TM) Endovascular System
6. Cardiums InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ember27/PRNewswire-FirstCall/--Stallergeneshasbeen...ultsandchildren,throughaMutualRecognitionProcedure...keted,wasthereferenceMemberstate. , Oralair(R...the,CzechRepublic,Estonia,France,Germany,Greece,Hu...alta,theNetherlands,Poland,Portugal,Romania,Slova...
(Date:11/25/2009)...v.25/PRNewswire/--BiotechfirmReplikinsLtd.,whichha...icthroughtheprediction,outbreak,andprogressofthecu...nalysisofthevirus.Thenewdatashowsthatthelethalityo...7(s.d.4.5)duringthevirus,scurrentoutbreakinthespri....d.0.1).TheH1N1virus,infectivitycount,however,rema...
(Date:11/25/2009)...ov.25/PRNewswire-Asia/--SinovacBiotechLtd.(SVA),a...aythatitexecuted,ajointventure(JV)agreementtoestab...vacDalian).TheJVwillresearch,develop,produce,andco...itsexpertise,andexperienceindevelopingandcommercia...tslanduserights,manufacturingfacilitiesand,establi...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--IES(Nasdaq: IESC ),al...ssystemsandservicesforthecommercial,industrialandr...usinessgrouphasbeenawardedacontractfromManhattanTo...-safetylab(BSL-4)replacementfacilityattheU.S.ArmyM...ID)atFortDetrickinFrederick,Md. ,, ThenewUSAMRI...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
... -- In the face of terrorism and catastrophic natu... improve survival for critically injured patients ...l assumptions underlying these systems -- such as ...st patients to the hospital first -- have rarely b..., for the first time, researchers at NewYork-Presb...
...esign Institute are using the tiniest organisms on...electricity. In a new study featured in the journ...ndrew Kato Marcus and colleagues Cesar Torres and ...may lead to commercialization of a promising micro...ny kind of waste, such as sewage or pig manure, an...
...UL, Minn., Jan. 3 /Xinhua-PRNewswire/ --,WuXi Phar...harmaceutical R&D,outsourcing services, has signed... Laboratory Services, Inc. (AppTec). The acquisiti... obtain biologics capabilities and expertise,gain ...nd its customer base,and addressable market size. ...
Other Biology Technology:Triage study challenges notions of emergency medical response to disaster 2Triage study challenges notions of emergency medical response to disaster 3Triage study challenges notions of emergency medical response to disaster 4Life at the jolt 2Life at the jolt 3Life at the jolt 4WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc. 2WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc. 3WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc. 4WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc. 5
(Date:11/26/2009)...he bare essentials of life, the indispensable ingr...e on its own? Can we describe the molecular anatom... functions as a system? These are just some of the...n the European Molecular Biology Laboratory (EMBL)...io Genmica (CRG) in Barcelona, Spain, set out to a...
(Date:11/25/2009)...rs and ambulance workers faced a terrifying rescue...ttled to save people from the collapsing Twin Towe...uated as many people as they could in an area whic... their jobs even harder was the problem of poor co...es jammed mobile networks with calls and the emerg...
(Date:11/25/2009)...tal to your health as what you eat, found research...Their experiments in mice revealed that the daily ...erthe body,s metabolic clearinghouseis mostly cont...ian clock as conventional wisdom had it. , "If ...mber of genes completely independent of the circad...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3 26amp 3B 238216 3BHairConfirm 26apos 3B Is First Drug Test of Its Kind to Report Low Medium High Usage 3B Now Available at Local Discount Drug Marts 48406 1 26amp 3B 238216 3BHairConfirm 26apos 3B Is First Drug Test of Its Kind to Report Low Medium High Usage 3B Now Available at Local Discount Drug Marts 48406 2 26amp 3B 238216 3BHairConfirm 26apos 3B Is First Drug Test of Its Kind to Report Low Medium High Usage 3B Now Available at Local Discount Drug Marts 48406 3New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 1New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 2New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 3New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 4New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 510 Things to do This Summer 21 48398 110 Things to do This Summer 21 48398 210 Things to do This Summer 21 48398 3
... 9, 2008 If youre worried about high cholesterol ... dont push aside bacon and eggs just yet. A new st...esearchers at Texas A&M University have discovered... muscle gain with exercising. Lead investigator St...inesiology, and Simon Sheather, head of the Depart...
...ion of soil, or geophagy, has important health ben...and her colleagues from the Musum National dHistoi...ysfunctional behavior, geophagy has evolved as a p.... In this particular study (1), to be published o...haften, geophagy increases the potency of ingested...
...aribbean have suffered significant changes due to ..., reports a study published in the Proceedings of ...owledged that coral reefs are declining worldwide ...author Camilo Mora at Dalhousie University, Halifa...e endangering a large number of species, from cora...
Other Biology News:Surprise -- cholesterol may actually pose benefits, study shows 2Down to earth remedies for chimps 2Humans have caused profound changes in Caribbean coral reefs 2Humans have caused profound changes in Caribbean coral reefs 3
Goat Anti-Sarcosine Oxidase Polyclonal Antibody, HRP Conjugated from Abcam
Mouse Anti-Rat ICAM Monoclonal Antibody, PE Conjugated from Antigenix America Inc.
Mouse Anti-C2 Monoclonal Antibody, Unconjugated, Clone 050-04 from Abcam
Mouse Anti-5-Methylcytosine Monoclonal Antibody, Unconjugated, Clone 33D3 from Eurogentec
Biology Products: